Abstract:Researchers and clinicians often rely on molecular assays like PCR to identify and monitor viral infections, instead of the resource-prohibitive gold standard of viral culture. However, it remains unclear when (if ever) PCR measurements of viral load are reliable indicators of replicating or infectious virus. The recent popularity of PCR protocols targeting subgenomic RNA for SARS-CoV-2 has caused further confusion, as the relationships between subgenomic RNA and standard total RNA assays are incompletely characterized and opinions differ on which RNA type better predicts culture outcomes. Here, we explore these issues by comparing total RNA, subgenomic RNA, and viral culture results from 24 studies of SARS-CoV-2 in non-human primates (including 2167 samples from 174 individuals) using custom-developed Bayesian statistical models. On out-of-sample data, our best models predict subgenomic RNA positivity from total RNA data with 91% accuracy, and they predict culture positivity with 85% accuracy. Further analyses of individual time series indicate that many apparent prediction errors may arise from issues with assay sensitivity or sample processing, suggesting true accuracy may be higher than these estimates. Total RNA and subgenomic RNA showed equivalent performance as predictors of culture positivity. Multiple cofactors (including exposure conditions, host traits, and assay protocols) influence culture predictions, yielding insights into biological and methodological sources of variation in assay outcomes–and indicating that no single threshold value applies across study designs. We also show that our model can accurately predict when an individual is no longer infectious, illustrating the potential for future models trained on human data to guide clinical decisions on case isolation. Our work shows that meta-analysis of in vivo data can overcome longstanding challenges arising from limited sample sizes and can yield robust insights beyond those attainable from individual studies. Our analytical pipeline offers a framework to develop similar predictive tools in other virus-host systems, including models trained on human data, which could support laboratory analyses, medical decisions, and public health guidelines. Although viral culture is the gold-standard method to detect replicating and infectious virus, decisions in virology research, clinical diagnostics, and public health often must rely on faster, cheaper PCR assays that detect viral genetic material. Substantial scientific effort has focused on assessing whether PCR assays (and what kind of PCR assays) can accurately predict culture outcomes, often finding conflicting results. In our study, we address this long-standing question by developing a customized statistical approach to analyze a large database of non-human primates experimentally infected with SARS-CoV-2. We demonstrate that two common PCR protocols can predict viral culture results with similarly high accuracy, as long as interpretations account for other factors such as exposure conditions, demographics, and assay protocols. For example, we show that inoculated tissues are more likely to be culture-positive (for a given PCR result) on the first day post infection than all later days post infection or non-inoculated tissue on any day–a finding that will clarify interpretation of results in experimental studies. Beyond these biological findings, we also showed that our framework can accurately identify when an individual is no longer infectious, showing the potential for future versions (trained on human data) to offer an individualized approach to ending isolation. Overall, our work presents a standardized framework to quantitatively predict viral culture outcomes based on faster and cheaper assays, which can be readily adapted to any other pathogen-host system with relevant data. Our work also demonstrates the power of (Bayesian) meta-analysis, which will be essential for the new era of data sharing in virology.

Cell Cultures for Virology: Usability, Advantages, and Prospects

A Microfluidic Cell Chip for Virus Isolation Via Rapid Screening for Permissive Cells

Traditional and Modern Cell Culture in Virus Diagnosis

Towards application of CRISPR-Cas12a in the design of modern viral DNA detection tools (Review)

Simplified Bioprinting-Based 3D Cell Culture Infection Models for Virus Detection

Cell identification, characterization, and documentation for use in the production of biological products

Current trends and new approaches for human norovirus replication in cell culture: a literature review

Three-dimensional Cell Culture Models for Investigating Human Viruses

Next-Generation Molecular Diagnostics Development by CRISPR/Cas Tool: Rapid Detection and Surveillance of Viral Disease Outbreaks

Progress in the study of virus detection methods: The possibility of alternative methods to validate virus inactivation

Application of next-generation sequencing technologies in virology

Efficient and accurate detection of viral sequences at single-cell resolution reveals putative novel viruses perturbing host gene expression

Viruses as gene delivery vectors: Application to gene function, target validation, and assay development

Expediting adenovirus titer assays via an algorithmic live-cell imaging technique

Predicting the presence of infectious virus from PCR data: A meta-analysis of SARS-CoV-2 in non-human primates

Recent Developments in Microfluidic Devices for in Vitro Cell Culture for Cell-Biology Research

Application of Molecular Diagnostic Techniques for Viral Testing

Microfluidic sample preparation for respiratory virus detection: A review

Single-Cell Virology: On-Chip, Quantitative Characterization of the Dynamics of Virus Spread from One Single Cell to Another

The diagnostic tools for viable but nonculturable pathogens in the food industry: Current status and future prospects

Microfluidic Device-Based Virus Detection and Quantification in Future Diagnostic Research: Lessons from the COVID-19 Pandemic